Strides Arcolab's US subsidary Strides and Stada Pharmaceuticals, the US subsidiary of Stada Arzneimittel AG, have signed a development and supply agreement for a prescription generic drug product for the US market.According to a release issued by Strides to the BSE, the product will be developed and manufactured by Strides at its US Soft Gelatin manufacturing facility exclusively for Stada's sale in the US.
